Ex vivo impact of functionalized carbon nanotubes on human immune cells

Nanomedicine

Volumn 7, Issue 2, 2012, Pages 231-243

  Delogu, Lucia Gemma ^a   Venturelli, Enrica ^b   Manetti, Roberto ^a   Pinna, Gérard Aimé ^a   Carru, Ciriaco ^a   Madeddu, Roberto ^a,c   Murgia, Luciano ^a   Sgarrella, Francesco ^a   Dumortier, Hélne ^b   Bianco, Alberto ^b  

^a UNIVERSITY OF SASSARI   (Italy)

^b CNRS   (France)

^c Istituto Nazionale Biostrutture and Biosistemi   (Italy)

Author keywords

activation; cytotoxicity; functionalized carbon nanotubes; human cells; immune system; PBMCs; uptake

Indexed keywords

MULTI WALLED NANOTUBE;

ADULT; APOPTOSIS; ARTICLE; B LYMPHOCYTE; CELL ACTIVATION; CELL VIABILITY; CONTROLLED STUDY; CYTOTOXICITY; EX VIVO STUDY; HUMAN; HUMAN CELL; IMMUNOCOMPETENT CELL; MALE; MONOCYTE; NATURAL KILLER CELL; PRIORITY JOURNAL; T LYMPHOCYTE;

CELLS, CULTURED; CYTOKINES; HUMANS; IMMUNITY, INNATE; MATERIALS TESTING; NANOTUBES, CARBON; T-LYMPHOCYTES;

EID: 84857588567     PISSN: 17435889     EISSN: 17486963     Source Type: Journal    
DOI: 10.2217/nnm.11.101     Document Type: Article

References (56)

1. Samad A, Alam MI, Saxena K. Dendrimers: A class of polymers in the nanotechnology for the delivery of active pharmaceuticals. Curr. Pharm. Des. 15, 2958-2969 (2009).
2. Baker JR. Dendrimer-based nanoparticles for cancer therapy. Hematol. Am. Soc. Hematol. Educ. Program 708-719 (2009).
3. Giljohann DA, Seferos DS, Daniel WL, et al. Gold nanoparticles for biology and medicine. Angew. Chem. Int. Ed. 49, 3280-3294 (2010).
4. Hirsch LR, Gobin AM, Lowery AR, et al. Metal nanoshells. Ann. Biomed. Eng. 34, 15-22 (2006).
5. Delogu LG, Magrini A, Bergamaschi A, et al. Conjugation of antisense oligonucleotides to PEGylated carbon nanotubes enables efficient knockdown of PTPN22 in T lymphocytes. Bioconjug. Chem. 20, 427-431 (2009).
6. Astruc D, Boisselier E, Ornelas C. Dendrimers designed for functions: from physical, photophysical, and supramolecular properties to applications in sensing, catalysis, molecular electronics, photonics, and nanomedicine. Chem. Rev. 110, 1857-1959 (2010).
7. Arvizo R, Bhattacharya R, Mukherjee P. Gold nanoparticles: opportunities and challenges in nanomedicine. Expert. Opin. Drug. Deliv. 7, 753-763 (2010).
8. Kim C, Agasti SS, Zhu Z, Isaacs L, Rotello VM. Recognition-mediated activation of therapeutic gold nanoparticles inside living cells. Nat. Chem. 2, 962-966 (2010).
9. Horcajada P, Chalati T, Serre C, et al. Porous metal-organic-framework nanoscale carriers as a potential platform for drug delivery and imaging. Nat. Mater. 9, 172-178 (2010).
10. Liu Z, Tabakman SM, Chen Z, Dai H. Preparation of carbon nanotube bioconjugates for biomedical applications. Nat. Protoc. 4, 1372-1381 (2009).
11. Liu Z, Tabakman S, Welsher K, Dai H. Carbon nanotubes in biology and medicine: in vitro and in vivo detection, imaging and drug delivery. Nano Res. 2, 85-120 (2009).
12. Ménard-Moyon C, Kostarelos K, Prato M, Bianco A. Functionalized carbon nanotubes for probing and modulating molecular functions Chem. Biol. 17, 107-115 (2010).
13. Firme CP, Bandaru PR. Toxicity issues in the application of carbon nanotubes to biological systems. Nanomedicine 6, 245-256 (2010).
14. Bianco A, Kostarelos K, Partidos CD, Prato M. Biomedical applications of functionalized carbon nanotubes. Chem. Commun. 5, 571-577 (2005).
15. Chen X, Kis A, Zettl A, Bertozzi CR. A cell nanoinjector based on carbon nanotubes. Proc. Natl Acad. Sci. USA 104, 8218-8222 (2007).
16. Star A, Gabriel JCP, Bradley K, Grüner G. Electronic detection of specific protein binding using nanotube FET devices. Nano Lett. 3, 459-463 (2003).
17. Shvedova AA, Kisin ER, Mercer R, et al. Unusual inflammatory and fibrogenic pulmonary responses to single-walled carbon nanotubes in mice. Am. J. Phys. Lung Cell. Mol. Physiol. 289, 698-708 (2005).
18. Lam CW, James JT, McCluskey R, Hunter RL. Pulmonary toxicity of single-wall carbon nanotubes in mice 7 and 90 days after intratracheal instillation. Toxicol. Sci. 77, 126-134 (2004).
19. Warheit DB, Laurence BR, Reed KL, et al. Comparative pulmonary toxicity assessment of single-wall carbon nanotubes in rats. Toxicol. Sci. 77, 117-125 (2004).
20. Dumortier H, Lacotte S, Pastorin G, et al. Functionalized carbon nanotubes are non-cytotoxic and preserve the functionality of primary immune cells. Nano Lett. 6, 1522-1528 (2006).
21. Wu P, Chen X, Hu N, et al. Biocompatible carbon nanotubes generated by functionalization with glycodendrimers. Angew. Chem. Int. Ed. 47, 5022-5025 (2008).
22. Schipper ML, Nakayama-Ratchford N, Davis CR, et al. A pilot toxicology study of single-walled carbon nanotubes in a small sample of mice. Nat. Nanotechnol. 3, 216-221 (2008).
23. Hu X, Cook S, Wang P, et al. In vitro evaluation of cytotoxicity of engineered carbon nanotubes in selected human cell lines. Sci. Total. Environ. 408, 1812-1817 (2010).
24. Nygaard UC, Hansen JS, Samuelsen M, et al. Single-walled and multi-walled carbon nanotubes promote allergic immune responses in mice. Toxicol. Sci. 109, 113-123 (2009).
25. Salvador-Morales C, Flahaut E, Sim E, et al. Complement activation and protein adsorption by carbon nanotubes. Mol. Immunol. 43, 193-201 (2006).
26. Samorì C, Sainz R, Ménard-Moyon C, et al. Potentiometric titration as a straightforward method to assess the number of functional groups on shortened carbon nanotubes. Carbon 48, 2447-2454 (2010).
27. Gaillard C, Cellot G, Li S, et al. Carbon nanotubes carrying cell adhesion peptides do not interfere with neuronal functionality. Adv. Mater. 21, 2903-2908 (2009).
28. Rejman J, Oberle V, Zuhorn IS, Hoekstra D. Size-dependent internalization of particles via the pathways of clathrin-and caveolae-mediated endocytosis. Biochem. J. 1, 159-169 (2004).
29. Kostarelos K, Lacerda L, Pastorin G, et al. Cellular uptake of functionalized carbon nanotubes is independent of functional group and cell type. Nat. Nanotechnol. 2, 108-113 (2007).
30. Russier J, Ménard-Moyon C, Venturelli E, et al. Oxidative biodegradation of single-and multi-walled carbon nanotubes Nanoscale 3, 893-896 (2011).
31. Shi Kam NW, Jessop TC, Wender PA, Dai H. Nanotube molecular transporters: internalization of carbon nanotube-protein conjugates into mammalian cells. J. Am. Chem. Soc. 126, 6850-6851 (2004).
32. Lacotte S, García A, Décossas M, et al. Interfacing functionalized carbon nanohorns with primary phagocytic cells. Adv. Mater. 20, 2421-2426 (2008).
33. Ben-Valid S, Dumortier H, Décossas M, et al. Polyaniline-coated single-walled carbon nanotubes: synthesis, characterization and impact on primary immune cells. J. Mater Chem. 20, 2408-2417 (2010).
34. Cai D, Blair D, Dufort FJ, et al. Interaction between carbon nanotubes and mammalian cells: characterization by flow cytometry and application. Nanotechnology 19, 1-10 (2008).
35. Al-Jamal KT, Toma FM, Yilmazer A, et al. Enhanced cellular internalization and gene silencing with a series of cationic dendron-multiwalled carbon nanotube: siRNA complexes. FASEB J. 24, 4354-4365 (2010).
36. Liang F, Chen B. A review on biomedical applications of single-walled carbon nanotubes. Curr. Med. Chem. 17, 10-24 (2010).
37. Kostarelos K, Bianco A, Prato M. Promises, facts and challenges for carbon nanotubes in imaging and therapeutics. Nat. Nanotechnol. 4, 627-633 (2009).
38. De Nicola M, Nuccitelli S, Gattia DM, et al. Effects of carbon nanotubes on human monocytes. Ann. NY Acad. Sci. 1171, 600-605 (2009).
39. Bottini M, Bruckner S, Nika K, et al. Multi-walled carbon nanotubes induce T lymphocyte apoptosis. Toxicol. Lett. 160, 121-126 (2006).
40. Albini A, Mussi V, Parodi A, et al. Interactions of single-wall carbon nanotubes with endothelial cells. Nanomedicine 6, 277-288 (2010).
41. Lu Q, Moore JM, Huang G, et al. RNA polymer translocation with single-walled carbon nanotubes. Nano Lett. 4, 2473-2477 (2004).
42. Singh R, Pantarotto D, Lacerda L, et al. Tissue biodistribution and blood clearance rates of intravenously administered carbon nanotube radiotracers. Proc. Natl Acad. Sci. USA 103, 3357-3362 (2006).
43. Yehia HN, Draper RK, Mikoryak C, et al. Single-walled carbon nanotube interactions with HeLa cells. J. Nanobiotechnol. 5, 8 (2007).
44. Raffa V, Ciofani G, Nitodas S, et al. Can the properties of carbon nanotubes influence their internalization by living cells? Carbon 46, 1600-1610 (2008).
45. Jin H, Heller DA, Sharma R, Strano MS. Size-dependent cellular uptake and expulsion of single-walled carbon nanotubes: single particle tracking and a generic uptake model for nanoparticles. ACS Nano 3, 149-158 (2009).
46. Sato Y, Yokoyama A, Shibata K, et al. Influence of length on cytotoxicity of multi-walled carbon nanotubes against human acute monocytic leukemia cell line THP-1 in vitro and subcutaneous tissue of rats in vivo. Mol. BioSyst. 1, 176-182 (2005).
47. Heister E, Lamprecht C, Neves V, et al. Higher dispersion efficacy of functionalized carbon nanotubes in chemical and biological environments. ACS Nano 4, 2615-2626 (2010).
48. Mitchell LA, Gao J, Wal RV, et al. Pulmonary and systemic immune response to inhaled multiwalled carbon nanotubes. Toxicol. Sci. 100, 203-214 (2007).
49. Zhang JC, Ji XY, Liu CL, Shen SG, Wang SX, Sun J. Effect of single-walled carbon nanotubes on primary immune cells in vitro. Front. Mater. Sci. 2, 228-232 (2008).
50. Hanley C, Thurber A, Hanna C, et al. The influences of cell type and ZnO nanoparticle size on immune cell cytotoxicity and cytokine induction. Nanoscale Res. Lett. 4, 1409-1420 (2009).
51. Shin SH, Ye MK, Kim HS, Kang HS. The effects of nano-silver on the proliferation and cytokine expression by peripheral blood mononuclear cells. Int. Immunopharmacol. 7, 1813-1818 (2007).
52. Lacerda L, Ali-Boucetta H, Herrero MA, et al. Tissue histology and physiology following intravenous administration of different types of functionalized multiwalled carbon nanotubes. Nanomedicine (Lond.) 3, 149-161 (2008).
53. Wu W, Wieckowski S, Pastorin G, et al. Targeted delivery of amphotericin B to cells by using functionalized carbon nanotubes. Angew. Chem. Int. Ed. 44, 6358-6362 (2005).
54. Crouzier D, Follot S, Gentilhomme E, et al. Carbon nanotubes induce inflammation but decrease the production of reactive oxygen species in lung. Toxicology 272, 39-45 (2010).
55. Pattani A, Patravale VB, Panicker L, Potdar PD. Immunological effects and membrane interactions of chitosan nanoparticles. Mol. Pharm. 6, 345-352 (2009).
56. Portevin D, Poupot M, Rolland O, et al. Regulatory activity of azabisphosphonate-capped dendrimers on human CD4+ T cell proliferation enhances ex-vivo expansion of NK cells from PBMCs for immunotherapy. J. Transl. Med. 7, 82 (2009).